Abionyx Pharma (ABNX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Operating Expenses | 5,897 | 9,642 |
| Operating Income | -5,897 | -9,642 |
| Interest Expense | 918 | 210 |
| Other Income | 215 | 2,152 |
| Pre-tax Income | -6,600 | -7,700 |
| Income Tax | -37 | 42 |
| Net Income Continuous | -6,563 | -7,742 |
| Net Income | $-6,563 | $-7,742 |
| EPS Basic Total Ops | -0.50 | -0.50 |
| EPS Basic Continuous Ops | -0.50 | -0.50 |
| EPS Diluted Total Ops | -0.50 | -0.50 |
| EPS Diluted Continuous Ops | -0.50 | -0.50 |
| EBITDA(a) | $-5,333 | $-7,334 |